Cost-effectiveness analysis of the 21 genes platform for guiding treatment decisions in early hormone positive breast cancer: perspective of the Brazilian public health system

Daniel Cubero; Fernando Fonseca; Beatriz Alves; Luiz Vinicius de Alcantaras; Auro del Giglio

doi:10.1055/s-0045-1807970

Brazilian Journal of Oncology, Table of Contents

CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1807970

PUBLIC POLICY, ACCESS, PHARMACOECONOMICS AND HEALTH MANAGEMENT

2081

POSTER PRESENTATION

Cost-effectiveness analysis of the 21 genes platform for guiding treatment decisions in early hormone positive breast cancer: perspective of the Brazilian public health system

Authors

Daniel Cubero
Fernando Fonseca
Beatriz Alves
Luiz Vinicius de Alcantaras
Auro del Giglio

Abstract

All articles of this category

Keywords

cost-effectiveness analysis - 21 genes platform - early hormone positive breast cancer - Brazilian public health system - decision-making

Bibliographical Record
Daniel Cubero, Fernando Fonseca, Beatriz Alves, Luiz Vinicius de Alcantaras, Auro del Giglio. Cost-effectiveness analysis of the 21 genes platform for guiding treatment decisions in early hormone positive breast cancer: perspective of the Brazilian public health system. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807970

Full Text